Moreover, eIF4G1 was previously shown to be significantly overexpressed in human inflammatory-type breast cancer, which exhibits a similar pathological phenotype to that of the 4T1 tumor, in which 40–50% of cells involved in the overall tumor mass are immune cells [43]. This evidence concerns the gene EIF4G1 and neoplasm.